Research and experimental development on natural sciences and engineering
PROPHYLAXIA SIGNS AS
Revenue 2024
NOK 3.9m
Operating profit
NOK 922,000
Equity
NOK −3.1m
Incorporated
2010
Share capital
NOK 150,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 3.9m | |
| Total operating costs | 2.9m | |
| Operating profit (EBIT) | 922k | |
| Net financial items | −381k | |
| Profit for the year | 541k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 2.5m | |
| of which current assets | 2.5m | |
| Equity | −3.1m | |
| Total liabilities | 5.6m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.